Joël Bockaert

Active 1972–2024

167
Papers
30,381
Citations
103
h-index
167
i10-index

Citations

Citations per year for Joël Bockaert1932: 1 citations1973: 6 citations1974: 10 citations1975: 16 citations1976: 25 citations1977: 18 citations1978: 24 citations1979: 15 citations1980: 22 citations1981: 19 citations1982: 24 citations1983: 25 citations1984: 29 citations1985: 31 citations1986: 42 citations1987: 45 citations1988: 50 citations1989: 88 citations1990: 108 citations1991: 114 citations1992: 163 citations1993: 170 citations1994: 213 citations1995: 206 citations1996: 203 citations1997: 216 citations1998: 252 citations1999: 277 citations2000: 270 citations2001: 316 citations2002: 353 citations2003: 341 citations2004: 306 citations2005: 280 citations2006: 265 citations2007: 301 citations2008: 308 citations2009: 233 citations2010: 217 citations2011: 254 citations2012: 273 citations2013: 198 citations2014: 180 citations2015: 165 citations2016: 183 citations2017: 131 citations2018: 120 citations2019: 423 citations2020: 488 citations2021: 418 citations2022: 297 citations2023: 201 citations2024: 340 citations2025: 160 citations1933–1972: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,248 citing papers, 32.6% of this breakdownFrance: 860 citing papers, 8.6% of this breakdownUnited Kingdom: 700 citing papers, 7% of this breakdownGermany: 562 citing papers, 5.6% of this breakdownItaly: 493 citing papers, 4.9% of this breakdownCanada: 402 citing papers, 4% of this breakdownChina: 371 citing papers, 3.7% of this breakdownJapan: 359 citing papers, 3.6% of this breakdownSpain: 275 citing papers, 2.8% of this breakdownSwitzerland: 207 citing papers, 2.1% of this breakdownSweden: 194 citing papers, 2% of this breakdownNetherlands: 191 citing papers, 1.9% of this breakdown
0%32.6%Other 21.2%

Fields

  • Neuroscience40.3%
  • Biochemistry, Genetics and Molecular Biology27.4%
  • Medicine25.1%
  • Psychology2.5%
  • Immunology and Microbiology1.1%
  • Nursing0.9%
  • Other2.7%

Topics

  • Neuroscience and Neuropharmacology Research12.5%
  • Receptor Mechanisms and Signaling8.4%
  • Neurotransmitter Receptor Influence on Behavior4.3%
  • Neuropeptides and Animal Physiology3.8%
  • Ion channel regulation and function3.2%
  • Neuroinflammation and Neurodegeneration Mechanisms2.3%
  • Other65.5%

Coauthors

All papers

Open in search
  1. International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bryan L. Roth, Anne Roumier, Gareth J. Sanger, Milt Teitler, Trevor Sharp, Carlos M. Villalón, Horst Vogel, Stephanie W. Watts, Daniël Hoyer - Pharmacological Reviews 2020 cited by 260

  2. Antidepressant-like effects of psychedelics in a chronic despair mouse model: is the 5-HT2A receptor the unique player?

    Authors: , , , - Neuropsychopharmacology 2024 cited by 75

  3. mTOR in Brain Physiology and Pathologies

    Authors: , - Physiological Reviews 2015 cited by 354

  4. Metabotropic glutamate receptors: From the workbench to the bedside

    Authors: , , , , , , , - Neuropharmacology 2010 cited by 637

  5. GLP-1 Mediates Antiapoptotic Effect by Phosphorylating Bad through a β-Arrestin 1-mediated ERK1/2 Activation in Pancreatic β-Cells

    Authors: , , , , , , , , - Journal of Biological Chemistry 2009 cited by 184

  6. Molecular tinkering of G protein‐coupled receptors: an evolutionary success

    Authors: , - The EMBO Journal 1999 cited by 1,508

  7. Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy

    Authors: , , , , , , , , , , - Brain 2007 cited by 422

  8. Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis

    Authors: , , , , , , , , , , , , , , , , , - Multiple Sclerosis Journal 2015 cited by 183

  9. Epileptiform Activity Induces Vascular Remodeling and Zonula Occludens 1 Downregulation in Organotypic Hippocampal Cultures: Role of VEGF Signaling Pathways

    Authors: , , , , , , - Journal of Neuroscience 2011 cited by 155

  10. Effects of a psychedelic 5-HT2A receptor agonist on anxiety-related behavior and fear processing in mice

    Authors: , , , , , , , , , - Neuropsychopharmacology 2022 cited by 43

  11. The Complex Formed by Group I Metabotropic Glutamate Receptor (mGluR) and Homer1a Plays a Central Role in Metaplasticity and Homeostatic Synaptic Scaling

    Authors: , , - Journal of Neuroscience 2021 cited by 54

  12. Differential signal transduction by five splice variants of the PACAP receptor

    Authors: , , , , , , - Nature 1993 cited by 1,194

  13. Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation

    Authors: , , , , - Cell and Tissue Research 2006 cited by 270

  14. The 5-HT6 receptor interactome: New insight in receptor signaling and its impact on brain physiology and pathologies

    Authors: , , , , - Neuropharmacology 2019 cited by 55

  15. Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2002 cited by 613

  16. Engineering GPCR signaling pathways with RASSLs

    Authors: , , , , , , , , , , , , , - Nature Methods 2008 cited by 254

  17. Presynaptic serotonin 2A receptors modulate thalamocortical plasticity and associative learning

    Authors: , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2016 cited by 134

  18. 5‐HT6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia

    Authors: , , , , , , , , , , , , , , - EMBO Molecular Medicine 2012 cited by 165

  19. Cdk5 induces constitutive activation of 5-HT6 receptors to promote neurite growth

    Authors: , , , , , , , , , - Nature Chemical Biology 2014 cited by 116

  20. Early administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer’s disease

    Authors: , , , , , , , , , , - Frontiers in Aging Neuroscience 2013 cited by 97

  21. 5-HT4Receptors Constitutively Promote the Non-Amyloidogenic Pathway of APP Cleavage and Interact with ADAM10

    Authors: , , , , , , , , - ACS Chemical Neuroscience 2012 cited by 93

  22. Anorexia induced by activation of serotonin 5-HT 4 receptors is mediated by increases in CART in the nucleus accumbens

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2007 cited by 186

  23. Novel and atypical pathways for serotonin signaling

    Authors: , , , , , - Faculty Reviews 2021 cited by 29

  24. Agonist-independent activation of metabotropic glutamate receptors by the intracellular protein Homer

    Authors: , , , , , , , , - Nature 2001 cited by 406